Certive Solutions Valuation

Is CBP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CBP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CBP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CBP's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CBP?

Key metric: As CBP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CBP. This is calculated by dividing CBP's market cap by their current revenue.
What is CBP's PS Ratio?
PS Ratio	1x
Sales	US$1.30m
Market Cap	US$1.28m

CBP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.5x
Enterprise Value/EBITDA	-7.6x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does CBP's PS Ratio compare to its peers?

The above table shows the PS ratio for CBP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	4.8x
EKG CardioComm Solutions	3x	n/a	CA$1.9m
CSPN CareSpan Health	0.3x	n/a	CA$952.3k
CHS Comprehensive Healthcare Systems	0.1x	n/a	CA$620.1k
TELE Telecure Technologies	15.9x	n/a	CA$7.6m
CBP Certive Solutions	1x	n/a	CA$1.8m

Price-To-Sales vs Peers: CBP is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (1.2x).

Price to Sales Ratio vs Industry

How does CBP's PS Ratio compare vs other companies in the CA Healthcare Services Industry?

7 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	2.2x	9.8%
CBP Certive Solutions	1x	n/a	US$1.28m
THNK Think Research	0.3x	6.5%	US$17.84m
CRBK Carebook Technologies	0.4x	n/a	US$4.41m

7 Companies		Estimated Growth	Market Cap
Industry Avg.	2.2x	31.1%
CBP Certive Solutions	1x	n/a	US$1.28m

No more companies

Price-To-Sales vs Industry: CBP is good value based on its Price-To-Sales Ratio (1x) compared to the North American Healthcare Services industry average (2.2x).

Price to Sales Ratio vs Fair Ratio

What is CBP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CBP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CBP's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeuPath Health

CA$9.0m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

6.3%

9.7%

Medical Facilities

CA$369.6m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

CA$15.55

3.2%

79.1%

Carebook Technologies

CA$6.2m

Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.

CRBK

CA$0.05

-37.5%

-28.6%